HCA | Ticker Profile - Titan Protect

HCA

HCA Healthcare

Health Care · Health Care Facilities · US

$372.13

Data: 2025-12-31

✗ ETHICAL FAIL

UNKNOWN MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$96.5B

Total market value of the company

Trailing P/E

15.00

Reasonably valued

Forward P/E

13.10

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.3%

Year-over-year revenue change

Profit Margin

0.0%

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

$513.10

+38% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 21 analysts covering this stock

About HCA Healthcare

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

https://www.hcahealthcare.com

Country: United States Employees: 230,000 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

80.2% FAIL

Debt must be below 33% of total assets

Cash Ratio

1.8% PASS

Interest-bearing cash below 33% of assets

Receivables

19.6% PASS

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$663.00

What our model estimates this business is worth per share

Margin of Safety

43.9%

Trading below fair value — margin of safety exists

Rating

AVOID

Overall assessment combining ethics, valuation, and quality

Percentile

61.6th

Ranks in the top 38% of our 13,571 screened universe

Ethical Score

10.0

Valuation Score

88.0

Quality Score

35.0

Combined

43.2

Trading at $435 against a fair value of $663, a 34% discount. Fails ethical screen (Debt ratio). Ranks better than 68% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.546

Good returns relative to risk taken

Kelly Fraction

0.0494

Modest edge detected — smaller position warranted

Calmar Ratio

0.418

Drawdown risk outweighs the returns — higher risk profile

Annual Return

11.9%

Historical annualised return based on price data

Max Drawdown

-28.5%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.19

Moves slightly more than the broader market

52W High

$556.52

33% below the year high

52W Low

$330.00

13% above the year low

Avg Volume

1,117,732

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

3.0%

Low short interest — limited bearish positioning

Div Yield

72.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$29.03

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

0.83

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.64

Like current ratio but excludes inventory — stricter test

Gross Margin

41.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

15.0%

Profit from core operations before interest and tax

Free Cash Flow

$5.7B

Positive — the business generates more cash than it spends

Revenue (TTM)

$76.4B

Total revenue over the last 12 months

Net Income

$6.8B

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$635.00

Target Median

$513.10

Target Low

$396.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date	Insider	Title	Shares	Value
2026-05-07	MARKS MIKE A	Chief Financial Officer	3,336	—
2026-04-28	MICHELSON MICHAEL W	Director	925	—
2026-04-28	CHIDSEY JOHN W	Director	809	—
2026-04-28	DEPARLE NANCY-ANN M. J.D.	Director	509	—
2026-04-28	RILEY WAYNE JOSEPH	Director	509	—
2026-04-28	FRIST THOMAS F III	Director and Beneficial Owner of more than 10% of a Class of Security	1,041	—
2026-04-28	JOHNSTON HUGH F.	Director	809	—
2026-04-28	SMITH ANDREA B	Director	509	—
2026-04-28	FRIST WILLIAM R.	Director and Beneficial Owner of more than 10% of a Class of Security	809	—
2026-02-18	MCALEVEY MICHAEL R.	Officer	1,694	$903,537

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
2026-04-20	Jonathan Jackson	Democrat	Sale	15K–50K
2026-04-15	Jonathan Jackson	Democrat	Sale	1K–15K
20 Apr2026	Jonathan Jackson	Democrat	sell	15K–50K
15 Apr2026	Jonathan Jackson	Democrat	sell	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2025-12-31

Before you go